Clinical Trials
8 trialsNCT05987644 2026-04-08
DURABLE
Hoosier Cancer Research Network
Phase 1/2 Recruiting
NCT04785287 2026-03-03
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT02407171 2023-10-31
Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC
Yale University
Phase 1/2 Completed
NCT00750269 2022-06-09
Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
Radiation Therapy Oncology Group
Phase 1/2 Completed
NCT01543672 2019-06-27
VOLUMES
The Netherlands Cancer Institute
Phase 1/2 Completed
NCT00471835 2017-01-19
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Phase 1/2 Withdrawn
NCT01222572 2015-06-04
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
Dana-Farber Cancer Institute
Phase 1/2 Terminated
NCT00238602 2012-07-13
Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
Stanford University
Phase 1/2 Completed